Analyzing Phreesia (NYSE:PHR) & Arcturis Data (OTCMKTS:SSYNF)

Phreesia (NYSE:PHR) and Arcturis Data (OTCMKTS:SSYNF) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, dividends, risk, institutional ownership and earnings.

Profitability

This table compares Phreesia and Arcturis Data’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Phreesia	1.85%	5.13%	3.12%
Arcturis Data	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of current recommendations and price targets for Phreesia and Arcturis Data, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Phreesia	1	9	9	0	2.42
Arcturis Data	0	0	0	0	0.00

Phreesia currently has a consensus target price of $16.65, indicating a potential upside of 45.12%. Given Phreesia’s stronger consensus rating and higher possible upside, research analysts plainly believe Phreesia is more favorable than Arcturis Data.

Earnings & Valuation

This table compares Phreesia and Arcturis Data”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Phreesia	$480.59 million	1.48	$2.31 million	$0.15	76.47
Arcturis Data	N/A	N/A	N/A	N/A	N/A

Phreesia has higher revenue and earnings than Arcturis Data.

Institutional and Insider Ownership

92.1% of Phreesia shares are held by institutional investors. 5.2% of Phreesia shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Phreesia beats Arcturis Data on 9 of the 9 factors compared between the two stocks.

About Phreesia

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.

About Arcturis Data

Arcturis Data Limited, a data company, uses data to support the discovery and development of new medicines. It supports the delivery of research across various phases of the clinical development pipeline covering various conditions and treatment types. The company translates patient pathways to support clinical development, inform policy, and advance research. It collaborates with research and industry experts to create disease-specific datasets. The company was formerly known as Sensyne Health Limited and changed its name to Arcturis Data Limited in October 2022. Arcturis Data Limited was incorporated in 2018 and is based in Kidlington, the United Kingdom.